Fingerprint
Dive into the research topics of 'High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial
Johann Hitzler, Todd Alonzo, Robert Gerbing, Amy Beckman, Betsy Hirsch, Susana Raimondi, Karen Chisholm, Shelton Viola, Lisa Brodersen, Michael Loken, Spencer Tong, Todd Druley, Maureen O'Brien, Nobuko Hijiya, Amy Heerema-McKenney, Yi Chang Wang, Reuven Shore, Jeffrey Taub, Alan Gamis, E. Anders Kolb
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations